Document Classification

Section Type: RESULTS

Text: At Cycle 6, the incidences of BTB/S for NGM/EE versus norethindrone acetate/EE were as follows : 18-24 years, 10. 9 % versus 29. 7 % (p <. 0001) ; 25-34 years, 10. 9 % versus 18. 6 % (p <. 001) ; > 34 years, 8. 1 % versus 19. 1 % (p <. 005) ; < or = 123 lb, 11. 0 % versus 25. 4 % (p <. 0001) ; 124-155 lb, 10. 0 % versus 22. 5 % (p <. 0001) ; and > 155 lb, 10. 0 % versus 18. 3 % (p <. 01).